🇺🇸 FDA
Patent

US 8884034

TOFA analogs useful in treating dermatological disorders or conditions

granted A61KA61K31/341A61K31/351

Quick answer

US patent 8884034 (TOFA analogs useful in treating dermatological disorders or conditions) held by Dermira (Canada), Inc. expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Dermira (Canada), Inc.
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/341, A61K31/351, A61K31/365, A61K31/4025